N-methyl-D-aspartate antagonists, schizophrenia, and neuroleptic malignant syndrome.
Weller
M
M
Kornhuber
J
J
D004298:Dopamine / Q000378:metabolism; D006801:Humans; D016202:N-Methylaspartate / Q000037:antagonists & inhibitors*; D009459:Neuroleptic Malignant Syndrome / Q000188:drug therapy*; D010300:Parkinson Disease / Q000188:drug therapy; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors; D012559:Schizophrenia / Q000188:drug therapy*
D016194:Receptors, N-Methyl-D-Aspartate; D016202:N-Methylaspartate; D004298:Dopamine